Hims & Hers: Still Growing After Breakup With Novo Nordisk

Hims & Hers Health, Inc. (NYSE: HIMS ) is one of the most interesting stocks on the market now and one that I rated a Buy back in May , considering it undervalued for its long-term growth potential.I analyze securities based on value investing, an owner's mindset, and a long-term horizon. I don't write sell articles as those are considered short theses, and I never recommend shorting.Former advisory representative at Fidelity. I do my own investing now and share my research here.Analyst’s Disclosure:I/we ha ...